Verastem Oncology is debuting a digital campaign to help people understand the differences in low-grade serous ovarian cancer.
Verastem's new campaign aims to make distinctions in rare type of ovarian cancer
When Tiffany Stout was first diagnosed with ovarian cancer in 2015, she didn’t immediately take in the fact that it was specifically the low-grade serous …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
